Aclidinium Bromide - CAS# 320345-99-1 ebeverine D6 Hydrochloride 15-diazahexacyclo[14

15-diazahexacyclo[14

PubMed PMID: 26075265

fibroblast growth factor receptor (FGFR) and platelet-derived growth factor receptor (PDGFR) tyrosine kinases

Smiles: C1OCC=CCOCC2=CC(=CC=C2)C2=CC=NC(NC3=CC1=C(C=C3)OCCN1CCCC1)=N2 |t:3|

Smiles: N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C3=CC=CN=C3NC2=O)C2=NC=CC=C21)C1=CC=CC(F)=C1F

Aclidinium Bromide - CAS# 320345-99-1 ebeverine D6 Hydrochloride 15-diazahexacyclo[14Aclidinium bromide is a long acting anticholinergic bronchodilator approved by the FDA in 2012 for use in the management of chronic obstructive pulmonary disease (COPD) which includes chronic bronchitis and emphysema. It is not however used for acute exacerbations. Aclidinium bromide is an inhalation powder promoted by Forest Pharmaceuticals in the US under the trade name Tudorza Pressair. It is also manufactured and marketed by Menarini